Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. Its primary product is ClearUP, is a medical device intended to relieve sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, including BestBuy.com and FSAStore.com. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.
P/S ratio for Tivic Health Systems, Inc. (TIVC)
P/S ratio as of 2023: 1.21
According to Tivic Health Systems, Inc.'s latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.21. At the end of 2022 the company had a P/S ratio of 3.36.
P/S ratio history for Tivic Health Systems, Inc. from 2019 to 2023
P/S ratio at the end of each year
| Year | P/S ratio |
|---|---|
| 2023 | 1.21 |
| 2022 | 3.36 |
| 2021 | 11.62 |
| 2020 | 13.90 |
| 2019 | 28.42 |